证券代码：300641 证券简称：正丹股份 公告编号：2025-021 江苏正丹化学工业股份有限公司 第五届监事会第九次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 1、江苏正丹化学工业股份有限公司（以下简称"公司"）第五届监事会第九 次会议于 2025 年 4 月 15 日以电子邮件等方式发出通知，并于 2025 年 4 月 18 日在公司会议室以现场结合通讯的方式召开。 2、本次会议应出席监事 3 名，实际出席监事 3 名。 3、本次会议由监事会主席周伟林先生主持，公司董事会秘书列席了会议。 4、本次会议的召开符合有关法律、行政法规、部门规章、规范性文件和公 司章程的规定。 二、监事会会议审议情况 1、审议通过《关于 2025 年第一季度报告的议案》 经审核，监事会认为：董事会编制和审核公司 2025 年第一季度报告的程序 符合法律、行政法规和中国证监会的规定，报告内容真实、准确、完整地反映了 上市公司的实际情况，不存在任何虚假记载、误导性陈述或者重大遗漏。 具体内容详见公司同日在巨潮资讯网（www.cninfo.c ...

证券代码：300641 证券简称：正丹股份 公告编号：2025-020 江苏正丹化学工业股份有限公司 第五届董事会第十次会议决议公告 一、董事会会议召开情况 1、江苏正丹化学工业股份有限公司（以下简称"公司"）第五届董事会第十 次会议于 2025 年 4 月 15 日以电子邮件等方式发出通知，并于 2025 年 4 月 18 日在公司会议室以通讯的方式召开。 2、本次会议应出席董事 9 名，实际出席董事 9 名。 3、本次会议由公司董事长曹正国先生主持，公司监事及高级管理人员列席 了会议。 4、本次会议的召开符合有关法律、行政法规、部门规章、规范性文件和公 司章程的规定。 二、董事会会议审议情况 （一）审议通过了《关于 2025 年第一季度报告的议案》 具体内容详见公司同日在巨潮资讯网（www.cninfo.com.cn）披露的《2025 年第一季度报告全文》（公告编号：2025-022）。 本议案已经公司董事会审计委员会审议并取得了明确同意的意见。 表决结果：9 票同意，0 票反对，0 票弃权。 三、备查文件 1、 公司第五届董事会第十次会议决议； 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， ...

Financial Performance - The company's revenue for Q1 2025 reached ¥853,160,085.29, representing a 64.67% increase compared to ¥518,115,169.27 in the same period last year[5] - Net profit attributable to shareholders surged to ¥388,521,351.01, a remarkable increase of 558.59% from ¥58,992,456.21 year-on-year[5] - Basic earnings per share rose to ¥0.7328, reflecting a 508.13% increase from ¥0.1205 in the same period last year[5] - Total operating revenue for the current period reached ¥853,160,085.29, a significant increase from ¥518,115,169.27 in the previous period, representing a growth of approximately 64.5%[19] - The company's net profit for the current period is 388,512,567.89 CNY, compared to 58,992,456.21 CNY in the previous period, representing a significant increase[20] - Operating profit for the current period is 456,810,743.83 CNY, while the previous period reported an operating profit of 69,475,197.04 CNY, indicating strong operational performance[20] - Total comprehensive income attributable to the parent company is 388,540,095.38 CNY, compared to 58,992,456.21 CNY in the previous period, reflecting robust growth[20] Cash Flow and Investments - The net cash flow from operating activities improved significantly to ¥419,787,592.66, compared to a negative cash flow of ¥174,877,684.98 in the previous year, marking a 340.05% increase[5] - Cash received from the sale of goods and services increased by 94.88% to ¥735,804,021.87, compared to ¥377,574,288.98 in Q1 2024[9] - Investment income for Q1 2025 was ¥821,365.51, a turnaround from a loss of ¥995,028.58 in the same period last year, reflecting a 182.55% improvement[9] - The company has increased its investment in financial products, with cash outflow for investments rising to ¥1,735,000,000.00, a 465.18% increase from ¥306,980,000.00 in the previous year[9] - Investment activities resulted in a net cash outflow of 787,463,815.45 CNY, compared to a net outflow of 112,151,788.50 CNY in the previous period, indicating increased investment activity[22] Assets and Liabilities - Total assets increased by 10.03% to ¥3,384,919,661.37 from ¥3,076,435,919.47 at the end of the previous year[5] - Current assets totaled ¥2,608,811,003.77, an increase from ¥2,312,401,904.11, indicating a growth of about 12.8%[17] - Non-current assets increased slightly to ¥776,108,657.60 from ¥764,034,015.36, showing a growth of approximately 1.8%[17] - Total liabilities decreased to ¥196,067,944.79 from ¥276,409,892.65, a reduction of approximately 29%[17] - The company's cash and cash equivalents decreased to ¥856,645,621.84 from ¥1,352,387,139.84, a decline of about 36.7%[16] - Inventory levels decreased to ¥185,546,364.18 from ¥223,457,743.44, reflecting a reduction of approximately 16.9%[16] Shareholder Information - The total number of common shareholders at the end of the reporting period is 60,122[11] - The largest shareholder, He Xing Enterprise Co., Ltd., holds 24.13% of shares, totaling 128,520,000 shares[11] - The second-largest shareholder, Hua Xing Investment (Zhenjiang) Co., Ltd., holds 22.36% of shares, totaling 119,085,800 shares[11] - The company has a share repurchase account holding 7,137,512 shares, representing 1.34% of the total share capital at the end of the reporting period[12] - The top ten shareholders include several investment firms and individuals, with the largest holding being 24.13%[11] - The company has established a unified action agreement among major shareholders, indicating a coordinated control structure[12] - The report indicates no changes in the top ten shareholders due to securities lending or borrowing activities[12] Strategic Plans - The company plans to invest in a production base in Malaysia, with a new subsidiary, Zhengdan Chemical SG Pte. Ltd., where the company will hold 70%[13] - The land purchase agreement for the Malaysian subsidiary covers an area of 80,900 square meters, with a total cost of 16.54 million Malaysian Ringgit[14] - The company is focused on expanding its market presence through strategic investments and partnerships in Southeast Asia[13] Financial Outlook - The company's weighted average return on equity improved to 12.98%, up by 9.19 percentage points from 3.79% year-on-year[5] - The company incurred income tax expenses of 68,092,685.54 CNY, compared to 10,431,284.38 CNY in the previous period, reflecting higher profitability[20] - The company has not yet audited the first quarter report for 2025, indicating that the financial results are preliminary[24]

Core Insights - As of April 17, 1695 companies have released their 2024 annual reports, with 947 reporting a year-on-year increase in net profit, while 748 reported a decline [1] - 1026 companies saw a year-on-year increase in operating revenue, whereas 669 experienced a decrease [1] - 750 companies reported simultaneous growth in both net profit and operating revenue, while 472 companies saw declines in both metrics [1] - A total of 180 companies achieved a doubling of their performance, with Zhengdan Co. leading with a staggering net profit growth of 11949.39% [1] Company Performance Summary - Zhengdan Co. (300641) reported earnings per share of 2.35 yuan, net profit of 118.99 million yuan, a year-on-year increase of 11949.39%, and operating revenue of 348.02 million yuan, up 126.31% [1] - Guangxi Energy (600310) had earnings per share of 0.043 yuan, net profit of 6.30 million yuan, a year-on-year increase of 3704.04%, but a significant decline in operating revenue by 76.48% to 393.16 million yuan [1] - North China Pharmaceutical (600812) reported earnings per share of 0.074 yuan, net profit of 12.70 million yuan, a year-on-year increase of 2496.80%, with operating revenue of 986.96 million yuan, down 2.48% [1] - Andisoo (600299) achieved earnings per share of 0.45 yuan, net profit of 120.43 million yuan, a year-on-year increase of 2208.66%, and operating revenue of 1.55 billion yuan, up 17.83% [1] - Other notable companies include Jiangsu Suopu (600746) with a net profit increase of 1029.62% and operating revenue growth of 18.43% [1] Additional Company Insights - Baoli Tianheng (688506) reported an impressive earnings per share of 9.25 yuan, net profit of 370.75 million yuan, and a remarkable year-on-year increase of 936.31% in net profit, with operating revenue of 582.27 million yuan [2] - Muyuan Foods (002714) achieved earnings per share of 3.30 yuan, net profit of 1.79 billion yuan, a year-on-year increase of 519.42%, and operating revenue of 13.79 billion yuan, up 24.43% [2] - Other companies like Xizi Clean Energy (002534) and Zhongchuan Defense (600685) reported varying performance metrics, with Xizi Clean Energy showing a decline in operating revenue by 20.33% [2]

Core Insights - Zhengdan Co., Ltd. reported exceptional financial results for 2024, with a revenue of 3.48 billion yuan, a year-on-year increase of 126.31%, and a net profit attributable to shareholders of 1.19 billion yuan, reflecting a staggering growth of approximately 11,949.30% [2][3][5] Financial Performance - The company achieved a net profit of 1.19 billion yuan and a net profit excluding non-recurring items of 1.18 billion yuan, with year-on-year growth rates of about 11,949.30% and 25,313.81% respectively [3][4] - Quarterly revenue for 2024 was reported as follows: Q1: 518 million yuan, Q2: 864 million yuan, Q3: 1.21 billion yuan, Q4: 884 million yuan, with year-on-year growth rates of 28.80%, 155.08%, 214.25%, and 115.40% respectively [3][4] - The operating cash flow net amount reached 892 million yuan, marking a year-on-year increase of 431.03% [7] Market Dynamics - The significant growth in performance is attributed to the permanent closure of TMA production lines by U.S. manufacturers, leading to a notable increase in overseas demand for Chinese TMA [5][6] - The sales volume and price of TMA, the company's main product, saw substantial increases compared to the previous year, contributing to the overall revenue growth [5][6] Operational Efficiency - The company has successfully enhanced its production capacity and efficiency, with a significant increase in the utilization rates of TMA and TOTM products, leading to reduced marginal costs and improved profitability [5][6] - The comprehensive gross margin and net margin for 2024 were reported at 41.49% and 34.19%, respectively, reflecting increases of 37.64 percentage points and 33.55 percentage points year-on-year [6] Strategic Initiatives - Zhengdan Co., Ltd. is expanding its production capabilities, with plans to invest 350 million yuan in a green upgrade project for TMA production, aimed at addressing current capacity shortages and filling market gaps [6] - The company has also initiated a project for high molecular specialty resin monomers, further diversifying its product offerings [6] Financial Health - As of the end of 2024, the company's asset-liability ratio was 8.98%, a significant decrease of 21.58 percentage points from the previous year, indicating strong financial stability [7] - The company proposed a cash dividend of 368 million yuan, with a dividend payout ratio of 30.92%, reflecting a cautious approach to profit distribution despite strong earnings [7]

Group 1 - The core viewpoint of the news is that Zhengdan Co., Ltd. (300641.SZ) has disclosed its 2024 annual report, highlighting significant institutional ownership and changes in fund disclosures [1] Group 2 - As of April 15, 2025, a total of 117 institutional investors hold shares in Zhengdan Co., Ltd., with a combined holding of 312 million shares, representing 58.57% of the total share capital [1] - The top ten institutional investors account for 58.20% of the total shares, with a decrease of 1.77 percentage points compared to the previous quarter [1] Group 3 - In the public fund sector, 111 new public funds have been disclosed this period, including Southern CSI 1000 ETF, Huaxia CSI 1000 ETF, and others [1] - One public fund, Hai Futong CSI 2000 Enhanced Strategy ETF, was not disclosed in this period compared to the previous quarter [1] Group 4 - From the perspective of foreign investment, one new foreign institution, Hong Kong Central Clearing Limited, has been disclosed this period [2] - Several foreign institutions, including Morgan Stanley & Co. International PLC, Goldman Sachs LLC, and UBS AG, were not disclosed in this period compared to the previous quarter [2]

（原标题：今日，重要发布会，事关经济！） 重要新闻 多项经济数据将公布，国新办今日上午10时将举行新闻发布会，介绍2025年一季度国民经济运行情况。 中国人民银行会同金融监管总局、中国证监会、国家外汇局联合印发《金融"五篇大文章"总体统计制度（试行）》。 工业和信息化部组织制定的强制性国家标准《电动汽车用动力蓄电池安全要求》日前发布。 3．外交部发言人林剑15日表示，消博会、广交会、中国发展高层论坛等活动的成功举行，展现了各方加强经贸合作，抵御单边主义、保护主义的 决心和信心。中国是世界的市场、各国的机遇，将以高质量发展和高水平对外开放为世界经济注入稳定性和正能量。 4．社会保险基金监管局发布2024年全国职业年金基金市场化投资运营情况。截至2024年年底，全国31个省（自治区、直辖市）、新疆生产建设兵 团和中央单位职业年金基金投资运营规模3.11万亿元。自2019年2月启动市场化投资运营以来，全国职业年金年均投资收益率4.42%。 5．4月15日，海关总署召开进出口企业、行业协会商会座谈会。会上，进出口企业和行业协会商会负责人介绍了企业、行业生产运行和稳订单拓 市场情况，并提出政策措施建议。大家一致表示，坚 ...

Core Viewpoint - Zhengdan Co., Ltd. has reported significant growth in both revenue and net profit for the year 2024, driven by its strong position in the TMA market and strategic expansion efforts [1][2]. Financial Performance - In 2024, the company achieved a revenue of 3.48 billion yuan, representing a year-on-year increase of 126.31% [1]. - The net profit attributable to shareholders reached 1.19 billion yuan, marking a staggering growth of 11,949.39% compared to the previous year [1]. - The company's stock price surged by 347.31% throughout 2024, making it a standout performer in the market [1]. Market Position and Product Focus - Zhengdan Co., Ltd. is the largest TMA supplier globally, with an annual production capacity of approximately 85,000 tons [2]. - The closure of a major TMA production facility by Ineos Joliet, which accounted for 27% of global capacity, has created a significant supply gap, benefiting Zhengdan [2]. - The company has capitalized on this opportunity, experiencing both volume and price increases for its products [2]. Industry Trends and Demand - The demand for TMA products is expected to grow, with projections indicating that the market size could reach 4.47 billion yuan by 2028 [3]. - The increasing quality requirements for TMA products driven by the development of the fine chemical industry present further growth opportunities for Zhengdan [3]. Diversification and Strategic Expansion - Zhengdan Co., Ltd. is not solely focused on TMA but is also expanding into the carbon nine aromatic hydrocarbon value chain [4]. - The company has integrated upstream raw materials efficiently, enhancing resource utilization and reducing external dependencies [4]. - Zhengdan is also developing high-value downstream products, creating a synergistic effect across its product lines [4]. - The company aims to strengthen its competitive edge through technological advancements, scale, and global delivery capabilities [4].

2024年，正丹股份实现营业收入3,480,231,502.00元，较上年同期的1,537,816,590.44元增长126.31%。从 产品结构来看，酸酐及酯类产品收入为2,789,636,533.98元，占营业收入比重80.16%，同比增长 155.11%，是营收增长的主要 驱动力 。这主要得益于美国TMA生产厂家关闭生产线，海外市场对中国 TMA需求大增，公司主要产品TMA销售数量及单价均大幅提升，同时TOTM产品销售也有所增长。从 销售地区来看，国内销售增长99.01%，国外销售更是激增212.86%，显示出公司在国内外市场的拓展均 取得显著成效。 净利润暴增，盈利能力显著提升 2025年4月16日，江苏正丹化学工业股份有限公司（以下简称" 正丹股份 "）发布2024年年度报告。报告 期内，公司多项财务数据出现大幅变动，其中归属于上市公司股东的净利润同比增长11,949.39%，经营 活动产生的现金流量净额同比增长431.03%。这两项数据的显著变化，既展现了公司在过去一年的卓越 表现，也引发了市场对其未来发展可持续性的关注。 关键财务指标解读 营收大幅增长，市场拓展成效显著 归属于上市公司股东的净利 ...

中国国际金融股份有限公司 关于江苏正丹化学工业股份有限公司 2024 年度募集资金存放与使用情况的专项核查意见 中国国际金融股份有限公司（以下简称"中金公司"、"保荐机构"）作为江 苏正丹化学工业股份有限公司（以下简称"公司"）持续督导工作的保荐机构， 根据《证券发行上市保荐业务管理办法》《深圳证券交易所创业板股票上市规则》 《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》 《上市公司监管指引第 2 号——上市公司募集资金管理和使用的监管要求》等相 关规定，对公司 2024 年度募集资金存放与使用情况进行了核查，具体情况如下： 一、募集资金基本情况 （一）实际募集资金金额、资金到位情况 1、首次公开发行股票募集资金 经中国证券监督管理委员会《关于核准江苏正丹化学工业股份有限公司首次 公开发行股票的批复》（证监许可[2017]406 号）核准，江苏正丹化学工业股份有 限公司（以下简称"公司"）于 2017 年 4 月首次向社会公开发行人民币普通股 （A 股）7,200 万股，发行价格 10.73 元/股，募集资金总额为人民币 77,256.00 万 元，扣除发行费用 7,374.09 ...